7‐(Chloroquinolin‐4‐yl) Sulfanyl Derivatives, Optimization of the Synthesis, In Silico ADMET Profiling Studies, and Evaluation of the Biological Activity Against Leishmania mexicana
ChemMedChem · 2026-11-12 · 21 (21)
DOI: 10.1002/cmdc.70550 ↗At a glance
Journal article in ChemMedChem, published online on 2026-10-29. Written by Angelo Gelvez and 13 co-authors. Institution: Unidad de Señalización Celular y Bioquímica de Parásitos, Instituto de Estudios Avanzados (IDEA), Caracas, Venezuela. Major MEDLINE topics: Leishmania mexicana, Antiprotozoal Agents. 34 references. Funded by: Fondo Nacional de Ciencia Tecnología e Innovación, Consejo de Desarrollo Científico y Humanístico, Universidad Central de Venezuela, National Fund for Science, Technology and Innovation.
Abstract (original language)
Leishmaniasis is a parasitic human infection that constitutes a major global health challenge due to limited therapeutic options, toxicity, resistance, and high costs of the drugs approved as therapy. In this study, a group of 7‐chloroquinoline derivatives ( 5 – 12 ) was synthesized via an optimized route and evaluated against the human parasite Leishmania mexicana . Compounds were fully characterized and showed favorable in silico ADME/Tox profiles, including high predicted gastrointestinal absorption (>93%), although limited solubility and potential hepatotoxicity were observed for several derivatives. Biological assays demonstrated significant antileishmanial activity. Interestingly, intracellular amastigote assays revealed nanomolar potency and very high selectivity index (SI), with compound 12 exhibiting IC 50 = 2.5 nM (SI = 21.030) and compound 9 IC 50 = 5.2 nM (SI = 7.384). Mechanistic studies demonstrated concentration‐dependent mitochondrial membrane depolarization and acidocalcisome alkalinization. Since these two organelles are both involved in bioenergetics and in parasite intracellular Ca 2+ homeostasis, the results support the notion that intracellular Ca 2+ disruption is an essential target for different drug actions. Overall, these findings support a multitarget mechanism and position these quinoline derivatives as promising chemical scaffolds for the development of improved antileishmanial strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Unidad de Señalización Celular y Bioquímica de Parásitos, Instituto de Estudios Avanzados (IDEA), Caracas, Venezuela.
- Facultad de Farmacia, Universidad Central de Venezuela, Caracas, Venezuela.
- Unidad de Productos Naturales, Facultad de Farmacia, Universidad Central de Venezuela, Caracas, Venezuela.
- Universidad ECOTEC, Samborondón, Guayaquil, Guayas, Ecuador.
- Laboratorio de Síntesis Orgánica, Facultad de Farmacia, Universidad Central de Venezuela, Caracas, Venezuela.
- Laboratorio de Biofísica, Instituto de Biología Experimental, Facultad de Ciencias, Universidad Central de Venezuela, Caracas, Venezuela.
ORCID profiles: Angelo Gelvez, Alírica Suárez, Katiuska Chávez, Hegira Ramírez, Jaime Charris, Gustavo Benaim
Funding
- Fondo Nacional de Ciencia Tecnología e Innovación
- Consejo de Desarrollo Científico y Humanístico, Universidad Central de Venezuela
- National Fund for Science, Technology and Innovation
- Council for Scientific and Humanistic Development, Central University of Venezuela
Cite
APA
Gelvez, A., Labrador-Fagúndez, L., Stella, B. G., Rivero, S., Ramirez, Y., Vidal, T., Martinez-Sotillo, N., Suárez, A., Chávez, K., Ramírez, H., Blanco, Z., Gutiérrez, J., Charris, J., & Benaim, G. (2026). 7‐(Chloroquinolin‐4‐yl) Sulfanyl Derivatives, Optimization of the Synthesis, In Silico ADMET Profiling Studies, and Evaluation of the Biological Activity Against Leishmania mexicana. ChemMedChem, 21(21). https://doi.org/10.1002/cmdc.70550
Vancouver
Gelvez A, Labrador-Fagúndez L, Stella BG, Rivero S, Ramirez Y, Vidal T, et al. 7‐(Chloroquinolin‐4‐yl) Sulfanyl Derivatives, Optimization of the Synthesis, In Silico ADMET Profiling Studies, and Evaluation of the Biological Activity Against Leishmania mexicana. ChemMedChem. 2026;21(21). doi:10.1002/cmdc.70550
BibTeX
@article{Gelvez2026,
author = {Gelvez, Angelo and Labrador-Fagúndez, Liesangerli and Stella, Bruno G and Rivero, Sugeins and Ramirez, Yaniska and Vidal, Thalia and Martinez-Sotillo, Nathalia and Suárez, Alírica and Chávez, Katiuska and Ramírez, Hegira and Blanco, Zuleyma and Gutiérrez, Joyce and Charris, Jaime and Benaim, Gustavo},
title = {7‐(Chloroquinolin‐4‐yl) Sulfanyl Derivatives, Optimization of the Synthesis, In Silico ADMET Profiling Studies, and Evaluation of the Biological Activity Against Leishmania mexicana},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {21},
doi = {10.1002/cmdc.70550}
}
EUVIMED